Vincent H Gattone

Author PubWeight™ 51.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The transmembrane protein meckelin (MKS3) is mutated in Meckel-Gruber syndrome and the wpk rat. Nat Genet 2006 3.19
2 Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med 2004 3.09
3 TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol 2012 2.24
4 Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008 2.09
5 Stem cell therapies benefit Alport syndrome. J Am Soc Nephrol 2009 1.83
6 Molecular diagnostics of Meckel-Gruber syndrome highlights phenotypic differences between MKS1 and MKS3. Hum Genet 2007 1.64
7 Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3. Hum Mol Genet 2009 1.61
8 Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev Biol 2007 1.60
9 Inversin modulates the cortical actin network during mitosis. Am J Physiol Cell Physiol 2013 1.52
10 CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 2004 1.52
11 A rat model of chronic kidney disease-mineral bone disorder. Kidney Int 2008 1.45
12 Renal cysts of inv/inv mice resemble early infantile nephronophthisis. J Am Soc Nephrol 2004 1.28
13 A conserved signal and GTPase complex are required for the ciliary transport of polycystin-1. Mol Biol Cell 2011 1.25
14 Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease. Lab Invest 2008 1.19
15 The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat. J Bone Miner Res 2011 1.18
16 Adult human CD133/1(+) kidney cells isolated from papilla integrate into developing kidney tubules. Biochim Biophys Acta 2011 1.11
17 VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice. Am J Physiol Cell Physiol 2007 1.10
18 A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD. J Bone Miner Res 2014 0.98
19 R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD). Nephrol Dial Transplant 2009 0.98
20 Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease. Exp Biol Med (Maywood) 2008 0.97
21 Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One 2013 0.97
22 Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res 2015 0.95
23 Parathyroid hormone enhances mechanically induced bone formation, possibly involving L-type voltage-sensitive calcium channels. Endocrinology 2003 0.95
24 Methodological assessment of acid-etching for visualizing the osteocyte lacunar-canalicular networks using scanning electron microscopy. Microsc Res Tech 2010 0.91
25 Disease stage characterization of hepatorenal fibrocystic pathology in the PCK rat model of ARPKD. Anat Rec (Hoboken) 2010 0.88
26 Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. Am J Nephrol 2011 0.88
27 Transglutaminase 2 accelerates vascular calcification in chronic kidney disease. Am J Nephrol 2013 0.87
28 c-myc antisense oligonucleotide treatment ameliorates murine ARPKD. Kidney Int 2002 0.87
29 Identification of the NC1 domain of {alpha}3 chain as critical for {alpha}3{alpha}4{alpha}5 type IV collagen network assembly. J Biol Chem 2010 0.86
30 Cadherin-11 controls otolith assembly: evidence for extracellular cadherin activity. Dev Dyn 2009 0.85
31 Lysophosphatidic acid is a modulator of cyst growth in autosomal dominant polycystic kidney disease. Cell Physiol Biochem 2011 0.83
32 Cadherin-2 participates in the morphogenesis of the zebrafish inner ear. J Cell Sci 2006 0.83
33 Calcimimetics inhibit renal pathology in rodent nephronophthisis. Kidney Int 2011 0.83
34 A telomerase immortalized human proximal tubule cell line with a truncation mutation (Q4004X) in polycystin-1. PLoS One 2013 0.82
35 The biomarker enriched proteome of autosomal dominant polycystic kidney disease cyst fluid. Proteomics Clin Appl 2009 0.82
36 A method to facilitate and monitor expression of exogenous genes in the rat kidney using plasmid and viral vectors. Am J Physiol Renal Physiol 2013 0.80
37 Protein composition of liver cyst fluid from the BALB/c-cpk/+ mouse model of autosomal recessive polycystic kidney disease. Proteomics 2009 0.80
38 2-Hydroxyestradiol slows progression of experimental polycystic kidney disease. Am J Physiol Renal Physiol 2011 0.80
39 Imaging glomeruli in renal biopsy specimens. Nephron Physiol 2006 0.78
40 Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment. Am J Nephrol 2013 0.78
41 Meckelin 3 is necessary for photoreceptor outer segment development in rat Meckel syndrome. PLoS One 2013 0.77
42 Functional imaging in small animals using X-ray computed tomography--study of physiologic measurement reproducibility. IEEE Trans Med Imaging 2005 0.76
43 Acceleration of the meckel syndrome by near-infrared light therapy. Nephron Extra 2011 0.75
44 Differential expression of renal proteins in a rodent model of Meckel syndrome. Nephron Exp Nephrol 2010 0.75
45 Prothymosin alpha as a cystogen. Kidney Int 2005 0.75
46 Ultrastructural study of the kidney in the coelacanth Latimeria chalumnae (Rhipidistia: Coelacanthini). Zoolog Sci 2014 0.75